Cargando…
Accelerating drug target inhibitor discovery with a deep generative foundation model
Inhibitor discovery for emerging drug-target proteins is challenging, especially when target structure or active molecules are unknown. Here, we experimentally validate the broad utility of a deep generative framework trained at-scale on protein sequences, small molecules, and their mutual interacti...
Autores principales: | Chenthamarakshan, Vijil, Hoffman, Samuel C., Owen, C. David, Lukacik, Petra, Strain-Damerell, Claire, Fearon, Daren, Malla, Tika R., Tumber, Anthony, Schofield, Christopher J., Duyvesteyn, Helen M.E., Dejnirattisai, Wanwisa, Carrique, Loic, Walter, Thomas S., Screaton, Gavin R., Matviiuk, Tetiana, Mojsilovic, Aleksandra, Crain, Jason, Walsh, Martin A., Stuart, David I., Das, Payel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284550/ https://www.ncbi.nlm.nih.gov/pubmed/37343087 http://dx.doi.org/10.1126/sciadv.adg7865 |
Ejemplares similares
-
Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS‐CoV‐2 Papain‐Like Protease
por: Brewitz, Lennart, et al.
Publicado: (2022) -
Penicillin Derivatives
Inhibit the SARS-CoV-2
Main Protease by Reaction with Its Nucleophilic Cysteine
por: Malla, Tika R., et al.
Publicado: (2022) -
Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 M(pro) inhibitors
por: Malla, Tika R., et al.
Publicado: (2021) -
In vitro selection of macrocyclic peptide inhibitors containing cyclic γ(2,4)-amino acids targeting the SARS-CoV-2 main protease
por: Miura, Takashi, et al.
Publicado: (2023) -
An end-to-end deep learning framework for translating mass spectra to de-novo molecules
por: Litsa, Eleni E., et al.
Publicado: (2023)